Angiodynamics (ANGO) Cash from Operations Growth (3y) (2013 - 2026)
Angiodynamics (ANGO) Cash from Operations Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 70.05% |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 16.81% |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 53.64% |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | - |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 25.17% |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | -9.84% |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 13.75% |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -33.35% |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | -8.92% |
| 10 | Angiodynamics | 558.11 Mn | 504.25 Mn | 46.77 Mn | 3.04% |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 3.04% |
| Feb 28, 2026 | -62.24% |
| Nov 30, 2025 | -14.66% |
| Aug 31, 2025 | 13.68% |
| May 31, 2025 | 30.01% |
| Feb 28, 2025 | -14.39% |
| Nov 30, 2024 | 8.41% |
| Aug 31, 2024 | -27.03% |
| May 31, 2024 | -25.71% |
| Feb 29, 2024 | -60.49% |
| Nov 30, 2023 | -22.81% |
| Aug 31, 2023 | -68.38% |
| May 31, 2023 | 60.21% |
| Feb 28, 2023 | 27.58% |
| Nov 30, 2022 | 8.10% |
| Aug 31, 2022 | -55.87% |
| May 31, 2022 | -30.05% |
| Feb 28, 2022 | -45.08% |
| Nov 30, 2021 | -46.89% |
| Aug 31, 2021 | -0.12% |